| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |